Each year, about 40% of the world’s children receive a GSK vaccine. Clinical vaccine pipeline. GSK’s clinical pipeline of 21 vaccine indications against 15 pathogens leverages a variety of ...

33; www.gsk.com). The vaccine production process itself can ... For example, parents want the best for their children and may have questions about the effects of a vaccine on their child.

The children’s pneumococcal vaccine GSK delivers to Dhaka is a global production: Mixing starts at the company’s plant in Singapore, vaccine batches are sent to Belgium and then France for ...

The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

The drugmaker GSK plunged into the messenger RNA-based vaccine market Wednesday, announcing it will buy the rights to experimental influenza and Covid-19 mRNA vaccines from the biotech CureVac.

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...

GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...

GSK global vaccines research and development head Philip ... The European Union approves it for active immunisation to prevent IMD in children from two years of age, adolescents, and adult population.